Titibiev can effectively treat hepatitis B
-
Last Update: 2020-07-04
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
two recent studies published by the University of Hong Kong and the University of Chinese of Hong Kong show that the new drug for the treatment of hepatitis B is more effective at suppressing the virus than two traditional drugsAt a joint press conference between the University of Hong Kong and the University of Chinese of Hong Kong, the results of the results of the new hepatitis B drug tribibdine and the combined drug ramivudine and Adfovirin were presentedIn both studies, more than 1,000 patients with chronic hepatitis B from around the world were involved, and the results showed that after a year of treatment, 60 per cent of patients taking tinpeddin had an undetectable level of the virus in their serum, compared with about 40 per cent of patients taking traditional drugsIn addition, tinbizin has fewer side effects and is less resistant than two traditional drugsProfessor Chen Liyuan, Director of the Centre for Liver Care at the School of Medicine of the Chinese School of Medicine in Hong Kong, said that the treatment of hepatitis B must be treated with safe and effective therapies as early as possible to significantly reduce the number of viruses(Smell)
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
